CD79A and congenital toxoplasmosis: Our study suggests that anti-Toxoplasma IgA is not a critical serological parameter for the diagnosis of congenital toxoplasmosis, and the recent withdrawal of commercialized reference anti-Toxoplasma IgA assays should not affect patient care.